TY - JOUR
T1 - Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride
AU - Ikoma, Yoko
AU - Watabe, Hiroshi
AU - Hayashi, Takuya
AU - Miyake, Yoshinori
AU - Teramoto, Noboru
AU - Minato, Kotaro
AU - Iida, Hidehiro
N1 - Funding Information:
This research was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Young Scientists (B) (No.20790839), Japan, Kobe Cluster I and II, Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; T.H.), and the MHLW (Ministry of Health, Labour and Welfare of Japan) Health Science Research Grant, H17-025 (T.H., H,I).
PY - 2009/10/1
Y1 - 2009/10/1
N2 - Positron emission tomography (PET) with [11C]raclopride is widely used to investigate temporal changes in the dopamine D2 receptor system attributed to the dopamine release. The simplified reference tissue model (SRTM) can be used to determine the binding potential (BPND) value using the time-activity curve (TAC) of the reference region as input function. However, in assessing temporal changes in BPND using the SRTM, multiple [11C]raclopride PET scans are required, and a second scan must be performed after the disappearance of the [11C]raclopride administered in the first scan. In this study, we have developed an extended multiple-injection SRTM to estimate the BPND change, from a single PET scan with multiple injections of [11C]raclopride, and we have validated this approach by performing numerous simulations and studies on monkeys. In the computer simulations, TACs were generated for dual injections of [11C]raclopride, in which binding conditions changed during the scans, and the BPND values before, and after, the second injection were estimated by the proposed method. As a result, the reduction in BPND was correlated, either with the integral of released dopamine, or with the administered mass of raclopride. This method was applied to studies on monkeys, and was capable of determining two identical BPND values when there were no changes in binding conditions. The BPND after the second injection decreased when binding conditions changed due to an increase in administered raclopride. An advantage of the proposed method is the shortened scan period for the quantitative assessment of the BPND change for neurotransmitter competition studies.
AB - Positron emission tomography (PET) with [11C]raclopride is widely used to investigate temporal changes in the dopamine D2 receptor system attributed to the dopamine release. The simplified reference tissue model (SRTM) can be used to determine the binding potential (BPND) value using the time-activity curve (TAC) of the reference region as input function. However, in assessing temporal changes in BPND using the SRTM, multiple [11C]raclopride PET scans are required, and a second scan must be performed after the disappearance of the [11C]raclopride administered in the first scan. In this study, we have developed an extended multiple-injection SRTM to estimate the BPND change, from a single PET scan with multiple injections of [11C]raclopride, and we have validated this approach by performing numerous simulations and studies on monkeys. In the computer simulations, TACs were generated for dual injections of [11C]raclopride, in which binding conditions changed during the scans, and the BPND values before, and after, the second injection were estimated by the proposed method. As a result, the reduction in BPND was correlated, either with the integral of released dopamine, or with the administered mass of raclopride. This method was applied to studies on monkeys, and was capable of determining two identical BPND values when there were no changes in binding conditions. The BPND after the second injection decreased when binding conditions changed due to an increase in administered raclopride. An advantage of the proposed method is the shortened scan period for the quantitative assessment of the BPND change for neurotransmitter competition studies.
KW - Binding potential
KW - Dopamine D receptor
KW - Multiple injections
KW - Positron emission tomography
KW - [C]raclopride
UR - http://www.scopus.com/inward/record.url?scp=67651036173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67651036173&partnerID=8YFLogxK
U2 - 10.1016/j.neuroimage.2009.05.099
DO - 10.1016/j.neuroimage.2009.05.099
M3 - Article
C2 - 19520172
AN - SCOPUS:67651036173
SN - 1053-8119
VL - 47
SP - 1639
EP - 1648
JO - NeuroImage
JF - NeuroImage
IS - 4
ER -